drug
mRNA-1403
Phase 3updated 6mo agoby $MRNA Moderna, Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying mRNA-1403
- phase2Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
- phase3A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
News(3)
- Moderna enjoys stable vaccine sales thanks to global COVID uptakeWhile Moderna preps an entry to the oncology market next year with a personalized cancer vaccine, COVID sales are holding steady with several other vaccine launches underway around the world.biospace · 12d ago
- Moderna’s norovirus vaccine plans in limbo in wake of phase 3 missModerna has scrapped plans to enroll a new cohort in a phase 3 trial of its norovirus vaccine and instead will meet with regulators to decide on next steps.fiercebiotech · 13d ago
- Moderna maintains 10% growth target despite Phase 3 norovirus missModerna’s norovirus vaccine failed in a Phase 3 trial, but the company still has faith in an ambitious revenue growth target thanks to ex-U.S. vaccine sales and a unanimous FDA adcomm win for mFLUS…biospace · 3mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that